These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 533259

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
    Scullard GH, Andres LL, Greenberg HB, Smith JL, Sawhney VK, Neal EA, Mahal AS, Popper H, Merigan TC, Robinson WS, Gregory PB.
    Hepatology; 1981; 1(3):228-32. PubMed ID: 6169615
    [No Abstract] [Full Text] [Related]

  • 3. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
    Scullard GH, Pollard RB, Smith JL, Sacks SL, Gregory PB, Robinson WS, Merigan TC.
    J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
    [Abstract] [Full Text] [Related]

  • 4. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M, Jardi R, Rodriguez-Frias F, Allende H, Cotrina M, Esteban R, Guardia J.
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [Abstract] [Full Text] [Related]

  • 5. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S.
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [Abstract] [Full Text] [Related]

  • 6. Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.
    Sacks SL, Scullard GH, Pollard RB, Gregory PB, Robinson WS, Merigan TC.
    Antimicrob Agents Chemother; 1982 Jan; 21(1):93-100. PubMed ID: 6177285
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M, Uchiumi K.
    J Hepatol; 1986 Jan; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Adenine arabinoside: hope in the treatment of chronic virus B hepatitis].
    Guerre J, Gaudric M, Couturier D, Levy C.
    Presse Med; 1983 Mar 19; 12(12):743-6. PubMed ID: 6220311
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
    Hoofnagle JH.
    J Hepatol; 1986 Mar 19; 3 Suppl 2():S73-80. PubMed ID: 2439579
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM.
    J Infect; 1988 May 19; 16(3):221-9. PubMed ID: 2456355
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.